Rapamycin and Semaglutide Interaction
Rapamycin and Semaglutide have an interaction requiring monitoring for interaction with 55% confidence. Both Rapamycin and Semaglutide affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). These compounds primarily affect different organ systems.
Compound Profiles
Rapamycin
mTOR Inhibitor | Longevity & Immunosuppression
Rapamycin exerts its effects by binding to the intracellular protein FKBP12, forming a complex that directly and specifically inhibits mechanistic target of rapamycin complex 1 (mTORC1). mTORC1 is a master nutrient-sensing kinase that integrates signals from growth factors, amino acids, energy status, and stress to regulate cell growth, proliferation, and metabolism.
View full profileSemaglutide
GLP-1 Receptor Agonist | Weight Loss & Diabetes
Mimics native GLP-1, binding to receptors to stimulate glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite via hypothalamic pathways..
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Rapamycin with Semaglutide?
Yes, but with caution. Both Rapamycin and Semaglutide affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.
Is Rapamycin and Semaglutide safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between Rapamycin and Semaglutide?
Both Rapamycin and Semaglutide affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 55% confidence and is inferred from pharmacological mechanism analysis.
How should I time Rapamycin and Semaglutide?
Rapamycin has a half-life of ~62 hours and Semaglutide has a half-life of ~7 days (168 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.